Product Recalls in Pennsylvania

Product recalls affecting Pennsylvania — including food, drugs, consumer products, medical devices, and vehicles distributed to Pennsylvania. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,919 recalls have been distributed to Pennsylvania in the last 12 months.

55,602 total recalls
2,919 in last 12 months

Showing 701720 of 13,473 recalls

DrugFebruary 6, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Morphine Sulfate Extended-Release Tablets Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 6, 2025· Padagis US LLC

Recalled Item: Estradiol Gel Recalled by Padagis US LLC Due to Defective Container: Some...

The Issue: Defective Container: Some packets may not be fully sealed, potentially...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 4, 2025· AvKARE

Recalled Item: Silodosin Capsules Recalled by AvKARE Due to Subpotent Drug: Out of...

The Issue: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 31, 2025· Fagron Compounding Services

Recalled Item: fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 31, 2025· Alvogen, Inc

Recalled Item: Fentanyl Transdermal System CII Recalled by Alvogen, Inc Due to Defective...

The Issue: Defective delivery system - patches could be multi-stacked, adhered one on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 30, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Potassium Chloride Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Failed Dissolution Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 29, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Atomoxetine Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund